Next Generation Sequencing (NGS) Sample Preparation Market Report 2026

The next generation sequencing (ngs) sample preparation market size has grown rapidly in recent years. It will grow from $3.6 billion in 2025 to $4.13 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to expansion of genomic research initiatives, rising adoption of ngs in clinical diagnostics, growth in precision medicine programs, increased availability of sequencing instruments, improvements in reagent performance.

The next generation sequencing (ngs) sample preparation market size is expected to see rapid growth in the next few years. It will grow to $7.1 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing use of ngs in routine diagnostics, rising demand for scalable sample preparation solutions, expansion of oncology and rare disease sequencing, growing investments in automated laboratories, increasing focus on workflow standardization. Major trends in the forecast period include increasing automation of ngs sample preparation workflows, rising demand for high-throughput library preparation kits, growing use of integrated ngs platforms, expansion of target enrichment techniques, enhanced focus on sample quality and reproducibility.

The increasing incidence of infectious diseases is expected to drive the growth of the next-generation sequencing (NGS) sample preparation market in the coming years. Infectious diseases are conditions caused by pathogens such as bacteria, viruses, fungi, or parasites that can be transmitted directly or indirectly between individuals. The rise in infectious diseases is attributed to factors such as increased global travel, rapid urbanization, climate change, antimicrobial resistance, and the emergence of new pathogens. Next-generation sequencing sample preparation plays a vital role in addressing the growing burden of infectious diseases by enabling fast and precise pathogen identification, supporting outbreak surveillance, transmission tracking, and the development of effective treatment strategies. For example, in September 2023, according to GOV.UK, a UK-based public sector information platform, tuberculosis (TB) cases in England increased by 7% during the first half of 2023 compared to the same period in 2022, with reported cases rising from 2,251 to 2,408. Consequently, the rising incidence of infectious diseases is expected to fuel the growth of the next-generation sequencing (NGS) sample preparation market.

Major companies operating in the next-generation sequencing (NGS) sample preparation market are increasingly emphasizing automation in sample preparation, including the adoption of digital microfluidics platforms, to improve efficiency, minimize manual errors, and streamline sample processing for more accurate and timely genomic analysis. Digital microfluidics platforms are advanced technologies that use electrical fields to manipulate small fluid volumes on a microchip, enabling precise and automated sample handling for applications such as NGS sample preparation. For example, in September 2023, INTEGRA Biosciences, a Switzerland-based provider of user-friendly solutions for liquid handling and media preparation, launched the MIRO CANVAS, a compact digital microfluidics platform designed for fully automated NGS sample preparation. This advanced system improves accuracy and efficiency by automating workflows, reducing hands-on time to approximately 15 minutes per run, and enabling immediate processing of clinical specimens. The MIRO CANVAS is designed to streamline NGS workflows and support advanced genomics research by preserving DNA integrity and reducing reagent consumption.

In January 2023, QIAGEN NV, a Netherlands-based biotechnology company, acquired Verogen for $150 million. This acquisition is intended to strengthen QIAGEN’s capabilities in forensic and genetic testing while expanding its product portfolio and market presence in the life sciences sector. Verogen is a US-based forensic genomics company specializing in next-generation sequencing solutions for forensic applications.

Major companies operating in the next generation sequencing (ngs) sample preparation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company (BD), Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Beckman Coulter, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Novogene Co. Ltd., Tecan Group Ltd, BGI Genomics Co. Ltd., Medgenome Inc., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., Oxford Nanopore Technologies Limited, New England Biolabs Inc., Pacific Biosciences of California Inc., Zymo Research Corporation, Psomagen Inc., Swift Biosciences Inc.

North America was the largest region in the next generation sequencing (NGS) sample preparation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period The regions covered in the next generation sequencing (ngs) sample preparation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the next generation sequencing (ngs) sample preparation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the NGS sample preparation market by increasing costs of imported reagents, enzymes, consumables, automated workstations, and quality control systems. Academic institutes, hospitals, and biotech companies in North America and Europe are most affected due to reliance on imported kits and instruments, while Asia-Pacific faces pricing pressure on export-oriented reagent manufacturing. These tariffs are raising operational costs and extending procurement cycles. At the same time, they are encouraging local reagent manufacturing, regional automation system assembly, and domestic development of sample preparation technologies.

The next generation sequencing (ngs) sample preparation market research report is one of a series of new reports that provides next generation sequencing (ngs) sample preparation market statistics, including next generation sequencing (ngs) sample preparation industry global market size, regional shares, competitors with a next generation sequencing (ngs) sample preparation market share, detailed next generation sequencing (ngs) sample preparation market segments, market trends and opportunities, and any further data you may need to thrive in the next generation sequencing (ngs) sample preparation industry. This next generation sequencing (ngs) sample preparation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Next-generation sequencing (NGS) sample preparation refers to the process of readying DNA or RNA samples for sequencing using Next-Generation Sequencing (NGS) technologies. This process involves several steps such as extraction, quantification, library preparation, and enrichment to ensure the samples are compatible with high-throughput sequencing and enable accurate genomic analysis.

The primary types of products and services in next-generation sequencing (NGS) sample preparation include workstations or instruments, reagents and consumables, and services. Workstations or instruments are specialized devices used for NGS sample preparation and sequencing that automate and simplify the various steps involved in preparing and analyzing genetic material. They are critical for achieving efficient and precise sequencing outcomes. The workflow steps include library preparation, target enrichment, sample extraction or isolation, fragmentation, sample quantification, library quantification, quality control (QC), and pooling, with technology types such as nanopore sequencing, sequencing by synthesis (SBS), single-molecule real-time (SMRT) sequencing, and ion semiconductor sequencing. Applications are categorized into diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture and animal research, and other areas for end users, including academic institutes and research centers, hospitals and clinics, pharmaceutical and biotech companies, and others.

The next generation sequencing (NGS) sample preparation market consists of revenues earned by entities by providing services such as library construction services, PCR amplification services, validation services, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The next generation sequencing (NGS) sample preparation market also includes sales of preparation kits, sample tracking software, automation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.